Like clinical trials, expanded access programs only happen under careful medical supervision of neurologists in the community.
Our programs partner with clinical researchers and drug developers to design treatment programs that are appropriate for patients.
ALS-ETF is building a network of research centers that are interested in including investigational drugs in the treatment options they can provide.
Interested patients should contact their clinic to find out if their clinic has joined our network.
If you are a medical facility treating ALS patients, please contact us here to learn more about joining our network.